SOPHARMA (SPH): Sales revenues for the first six months of 2017 - raport 53
Raport ESPI
UNI - EN REPORT No53/2017
Sopharma AD notifies that for June 2017 the Company recorded an increase of sales revenues of 31% compared to the same month of 2016, including 2% decrease of domestic sales and 59% increase of export sales.
For the first six months of this year, revenues from sales increased by 18% compared to the same period of 2016, including 1% increase of domestic sales and a 30% increase of export sales.
